Pfizer's Covid-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalisation and death for high-risk seniors, according to a study published this week.The results from a 109,000-patient...
Full ArticlePfizer Covid pill showed no benefit in younger adults - study
New Zealand Herald
0 shares
1 views
You might like
Related news coverage
Study: Pfizer COVID Treatment Pill Showed No Benefit To Younger Adults
Newsy
Watch VideoPfizer's COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of..
-
Study: Pfizer COVID pill showed no benefit in younger adults
SeattlePI.com
-
Pfizer's COVID-19 antiviral Paxlovid not as effective in younger adults - study
SeekingAlpha
-
Study: Pfizer COVID pill showed no benefit in younger adults
CTV News
-
Pfizer COVID shots appear 73% effective in children under 5
SeattlePI.com